Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for marrow failure in Fanconi anemia and acquired aplastic anemia without transplant options
2004-004914-18Phase 2Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jul 2005
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of etanercept in Fanconi anemia (FA) and aplastic anemia (2 cohorts), sponsored by Istituto Giannina Gaslini. Started Jul 2005; status: active.
02
Drugs
etanercept
03
Conditions
Fanconi anemia (FA)aplastic anemia
Beyond the preview
Go deeper on 2004-004914-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004914-18.